Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736031 | 0.98 | ABCG2 (0.32) | ABCG2NPY5RTP53CYP1A2CYP3A4 | |
| SCHEMBL21735884 | 0.95 | CYP1A2 (0.32) | TP53CYP1A2CYP3A4CYP2D6TSHR | |
| SCHEMBL21736570 | 0.94 | ABCG2 (0.32) | ABCG2TP53CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL21735861 | 0.92 | TUBB4A (0.34) | — | |
| SCHEMBL21736128 | 0.91 | — | — | |
| SCHEMBL21474883 | 0.91 | PTGER4 (0.35) | NPY5R | |
| SCHEMBL21736228 | 0.91 | PTGER4 (0.35) | NPY5R | |
| SCHEMBL20670045 | 0.90 | TUBB4A (0.30) | — | |
| SCHEMBL21735971 | 0.90 | — | — | |
| SCHEMBL21736138 | 0.90 | PGR (0.34) | ABCG2TP53CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | ABCG2 2184/4885NPY5R 4334/4885TP53 4332/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | ABCG2 2184/4885NPY5R 4334/4885TP53 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.